Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.drreddys.com | |
Market Cap | 73,968.14 Cr. | |
Enterprise Value(EV) | 74,047.24 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 218.83 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 20.30 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 32.80 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 1,321.92 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 3.36 | Calculated using Price: 4,441.90 |
Dividend Yield | 0.68 | Period Ending 2022-03 |
No. of Shares Subscribed | 16.65 Cr. | 166,523,639 Shares |
FaceValue | 5 | |
Company Profile | ||
The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations. |
1 Day |
|
+0.20% |
1 Week |
|
+2.24% |
1 Month |
|
+4.15% |
3 Month |
|
-0.81% |
6 Month |
|
+5.34% |
1 Year |
|
+2.94% |
2 Year |
|
-8.45% |
5 Year |
|
+104.04% |
10 Year |
|
+139.79% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 27.88 | 26.63 | 18.95 | 10.20 | 7.40 | 14.42 | 13.38 | 11.53 | 11.55 | |
Return on Capital Employed (%) | 24.77 | 22.69 | 19.55 | 9.77 | 8.21 | 13.41 | 10.81 | 15.24 | 14.27 | |
Return on Assets (%) | 13.47 | 13.67 | 11.05 | 6.14 | 4.23 | 8.66 | 8.95 | 8.01 | 7.82 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 7,865 | 9,853 | 12,570 | 12,262 | 12,572 | 14,024 | 15,599 | 17,642 | 19,212 | 20,775 | |
Non Curr. Liab. | 2,182 | 1,678 | 877 | 456 | 2,538 | 2,113 | -808 | -197 | -508 | -345 | |
Curr. Liab. | 5,790 | 6,821 | 6,347 | 8,420 | 6,894 | 5,897 | 7,214 | 8,104 | 9,766 | 7,987 | |
Minority Int. | |||||||||||
Equity & Liab. | 15,838 | 18,353 | 19,794 | 21,138 | 22,004 | 22,034 | 22,005 | 25,548 | 28,470 | 28,417 | |
Non Curr. Assets | 5,512 | 6,476 | 8,000 | 11,454 | 11,505 | 10,924 | 9,406 | 10,998 | 10,682 | 11,163 | |
Curr. Assets | 10,326 | 11,877 | 11,794 | 9,684 | 10,498 | 11,110 | 12,599 | 14,550 | 17,788 | 17,254 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 15,838 | 18,353 | 19,794 | 21,138 | 22,004 | 22,034 | 22,005 | 25,548 | 28,470 | 28,417 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 13,415 | 15,023 | 15,568 | 14,196 | 14,281 | 15,448 | 17,517 | 19,048 | 21,545 | 23,829 | |
Other Income | 170 | 274 | 295 | 172 | 155 | 338 | 621 | 291 | 485 | 1,075 | |
Total Income | 13,585 | 15,297 | 15,863 | 14,368 | 14,436 | 15,786 | 18,138 | 19,339 | 22,030 | 24,905 | |
Total Expenditure | -10,165 | -11,530 | -11,983 | -11,724 | -11,930 | -12,270 | -15,047 | -15,178 | -17,778 | -18,600 | |
PBIDT | 3,421 | 3,768 | 3,880 | 2,644 | 2,506 | 3,516 | 3,091 | 4,161 | 4,252 | 6,305 | |
Interest | -127 | -108 | -83 | -63 | -79 | -89 | -98 | -97 | -96 | -139 | |
Depreciation | -648 | -760 | -939 | -1,027 | -1,077 | -1,135 | -1,163 | -1,229 | -1,165 | -1,228 | |
Taxation | -683 | -563 | -751 | -297 | -438 | -386 | 140 | -932 | -879 | -1,334 | |
Exceptional Items | |||||||||||
PAT | 1,963 | 2,336 | 2,108 | 1,257 | 912 | 1,906 | 1,970 | 1,904 | 2,112 | 3,604 | |
Minority Interest | |||||||||||
Share Associate | 23 | 35 | 34 | 44 | 56 | 48 | 70 | 40 | |||
Other Related Items | |||||||||||
Consolidated Net Profit | 1,963 | 2,336 | 2,131 | 1,292 | 947 | 1,950 | 2,026 | 1,952 | 2,183 | 3,644 | |
Adjusted EPS | 115 | 137 | 125 | 78 | 57 | 117 | 122 | 117 | 131 | 219 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 1,378 | 1,970 | 2,524 | 3,263 | 2,144 | 1,803 | 2,870 | 2,984 | 3,570 | 2,811 | |
Cash Fr. Inv. | -1,446 | -1,694 | -2,265 | -2,039 | -1,840 | -1,488 | -773 | -492 | -2,266 | -2,639 | |
Cash Fr. Finan. | -157 | -24 | -433 | -1,700 | -369 | -444 | -2,133 | -2,516 | -30 | -242 | |
Net Change | -225 | 251 | -174 | -477 | -65 | -129 | -35 | -24 | 1,275 | -70 | |
Cash & Cash Eqvt | 520 | 862 | 583 | 492 | 378 | 254 | 223 | 196 | 1,482 | 1,485 |
Fri, 03 Feb 2023
Analysts/Institutional Investor Meet/Con. Call Updates
|
|
Tue, 31 Jan 2023
Analysts/Institutional Investor Meet/Con. Call Updates
|
|
Mon, 30 Jan 2023
Analysts/Institutional Investor Meet/Con. Call Updates
|
Tue, 07 Feb 2023 |
|
|
|
|
|